HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a ...
Mark McMahan, Chief Commercial Officer of BMI, added “We’re excited to partner with Sanara MedTech to introduce OsStic to the U.S. market. This collaboration combines BMI’s technology leadership with ...
Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...
Morning Overview on MSN
AI now decodes sweat to spot early signs of disease
Sweat is turning into one of medicine’s most revealing data streams, and artificial intelligence is learning how to read it.
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL Marks the start of the second Phase IIa trial to evaluate first-in-class monoclonal antibody CIT-013 this year, following the ...
The sunbird Syn (TM) assay accurately classified Parkinson's disease-positive blood samples with 81% accuracy through the direct detection of EV-bound aggregated alpha-synuclein proteins -- -- With no ...
An offshore trial has found a link between kidney malfunction and Alzheimer's, while a local biotech legend takes a different ...
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have published a review analyzing the therapeutic ...
Aethlon Medical’s Hemopurifier® is an investigational extracorporeal device designed to bind and remove harmful EVs from the ...
Recent research identifies specific biological alterations in the brain’s reward center that correlate with depression. The study reveals that the physiological signs associated with a history of ...
FRAMINGHAM, MA / ACCESS Newswire / November 19, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback